Jim Simons Trinity Biotech PLC Transaction History

Renaissance Technologies LLC

$63.1 Billion
Q3 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	SELL	$0.38 - $0.7 $3,534 - $6,510	-9,300 Reduced 0.68%	1,353,898 $581,000
Q3 2023 Nov 14, 2023	SELL	$0.68 - $1.08 $6,528 - $10,368	-9,600 Reduced 0.7%	1,363,198 $1 Million
Q2 2023 Aug 11, 2023	SELL	$0.84 - $1.14 $3,444 - $4,674	-4,100 Reduced 0.3%	1,372,798 $1.31 Million
Q1 2023 May 12, 2023	SELL	$0.87 - $1.18 $14,389 - $19,517	-16,540 Reduced 1.19%	1,376,898 $1.29 Million
Q4 2022 Feb 13, 2023	SELL	$0.98 - $6.15 $43,904 - $275,520	-44,800 Reduced 3.11%	1,393,438 $1.38 Million
Q3 2022 Nov 14, 2022	SELL	$1.09 - $5.45 $70,956 - $354,784	-65,098 Reduced 4.33%	1,438,238 $1.54 Million
Q2 2022 Aug 12, 2022	BUY	$0.96 - $1.44 $33,504 - $50,256	34,900 Added 2.38%	1,503,336 $1.84 Million
Q1 2022 May 13, 2022	SELL	$0.92 - $1.44 $92,109 - $144,171	-100,119 Reduced 6.38%	1,468,436 $1.56 Million
Q4 2021 Feb 11, 2022	SELL	$1.43 - $2.25 $254,948 - $401,143	-178,286 Reduced 10.21%	1,568,555 $2.24 Million
Q3 2021 Nov 12, 2021	SELL	$1.82 - $2.94 $187,898 - $303,528	-103,241 Reduced 5.58%	1,746,841 $3.77 Million
Q2 2021 Aug 13, 2021	BUY	$2.77 - $4.18 $14,179 - $21,397	5,119 Added 0.28%	1,850,082 $5.44 Million
Q1 2021 May 13, 2021	SELL	$3.26 - $6.64 $201,608 - $410,637	-61,843 Reduced 3.24%	1,844,963 $6.94 Million
Q4 2020 Feb 10, 2021	BUY	$1.95 - $4.77 $449,545 - $1.1 Million	230,536 Added 13.75%	1,906,806 $7.27 Million
Q3 2020 Nov 13, 2020	BUY	$1.68 - $3.17 $164,908 - $311,167	98,160 Added 6.22%	1,676,270 $3.39 Million
Q2 2020 Aug 13, 2020	BUY	$0.88 - $2.55 $619,418 - $1.79 Million	703,885 Added 80.52%	1,578,110 $3.44 Million
Q1 2020 May 14, 2020	BUY	$0.62 - $1.47 $115,979 - $274,984	187,064 Added 27.22%	874,225 $962,000
Q4 2019 Feb 13, 2020	BUY	$0.69 - $1.2 $4,685 - $8,149	6,791 Added 1.0%	687,161 $710,000
Q3 2019 Nov 13, 2019	SELL	$1.21 - $2.59 $6,202 - $13,276	-5,126 Reduced 0.75%	680,370 $823,000
Q2 2019 Aug 12, 2019	BUY	$1.57 - $3.02 $112,545 - $216,488	71,685 Added 11.68%	685,496 $1.13 Million
Q1 2019 May 14, 2019	BUY	$2.31 - $3.22 $41,811 - $58,282	18,100 Added 3.04%	613,811 $1.75 Million
Q4 2018 Feb 13, 2019	BUY	$2.14 - $4.26 $1.27 Million - $2.54 Million	595,711 New	595,711 $1.36 Million

Others Institutions Holding TRIB

# of Institutions

Shares Held

30.2K

Call Options Held

Put Options Held

Wealthsource Partners, LLC

30.2K
Shares

$41,374
0.0% of portfolio

View Full List

About TRINITY BIOTECH PLC

Ticker TRIB
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 38,107,600
Market Cap $52.2M
Description
Trinity Biotech plc acquires, develops, manufactures, and markets medical diagnostic products for the clinical laboratory and point-of-care (POC) segments of the diagnostic market in the Americas, Africa, Asia, and Europe. The company offers clinical laboratory products, including diagnostic tests and instrumentation, which detect infectious dis...

More about TRIB

Track Jim Simons's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.

Account